Peritoneal dialysis (PD) is a renal replacement therapy used to treat patients with end-stage renal disease (ESRD) by removing waste products and excess fluid from the blood through the peritoneum in the abdomen. PD is an alternative to hemodialysis, allowing patients greater flexibility and often better quality of life.
The global peritoneal dialysis market is driven by the rising prevalence of chronic kidney disease (CKD), increasing ESRD cases, and growing preference for home-based dialysis therapies. The market includes PD solutions, cyclers, catheters, and accessories.
The global peritoneal dialysis market was valued at USD 4.52 billion in 2022, increasing at a CAGR of 5.86% from 2022 to 2030 and anticipated to reach USD 7.13 billion by 2030.
Key Highlights:
-
Rising incidence of diabetes and hypertension fueling CKD cases.
-
Increasing awareness and adoption of home dialysis treatments.
-
Innovations in PD fluids and automated PD systems.
2. Market Dynamics
2.1 Drivers
-
Increasing CKD and ESRD Prevalence: Growing patient pool requiring dialysis therapy worldwide.
-
Benefits of Home Dialysis: Convenience, better patient comfort, and cost-effectiveness compared to in-center hemodialysis.
-
Technological Advancements: Development of biocompatible PD fluids and portable automated PD devices improving treatment outcomes.
2.2 Restraints
-
Risk of Peritonitis: Infection risk associated with PD can lead to complications.
-
Limited Patient Awareness: Lack of awareness and training in some regions reduces PD adoption.
-
High Initial Cost of Automated PD Systems: Affordability concerns in low- and middle-income countries.
2.3 Opportunities
-
Emerging Markets Growth: Expanding healthcare infrastructure and government initiatives in Asia-Pacific and Latin America.
-
Product Innovations: New PD solutions with improved biocompatibility and lower infection rates.
-
Telemedicine and Remote Monitoring: Enhancing patient adherence and care management.
2.4 Challenges
3. Segment Analysis
3.1 By Product Type
-
PD Solutions (Dextrose-based, Icodextrin-based, Amino acid-based)
-
Dialysis Equipment (Cyclers, Connectors, Catheters)
-
PD Accessories (Bags, Tubing, Transfer sets)
3.2 By Type
3.3 By End User
3.4 By Region
-
North America – Large patient base and advanced healthcare facilities.
-
Europe – Strong reimbursement policies and awareness programs.
-
Asia-Pacific – Fastest growing market due to increasing CKD prevalence and healthcare investments.
-
Latin America and Middle East & Africa – Emerging markets with growing focus on renal care.
4. Some of the Key Market Players
-
Baxter International Inc.
-
Fresenius Medical Care AG & Co. KGaA
-
Nipro Corporation
-
B. Braun Melsungen AG
-
Terumo Corporation
-
Medtronic plc
-
Hospira (Pfizer Inc.)
-
Gambro (part of Baxter)
-
DaVita Inc.
-
Shandong Weigao Group Medical Polymer Co., Ltd.
5. Report Description
This comprehensive report offers an in-depth analysis of the global peritoneal dialysis market, covering market size, trends, growth drivers, challenges, and competitive landscape from 2025 to 2032. It provides insights into product innovation, regulatory environment, and emerging market opportunities, equipping stakeholders to make informed strategic decisions. The report integrates both qualitative and quantitative data, market forecasts, and detailed company profiles.
Request Sample PDF @ https://www.thebrainyinsights.com/enquiry/sample-request/13236
6. Table of Contents
-
Executive Summary
-
Market Introduction
-
Research Methodology
-
Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
-
Market Segmentation
5.1 By Product Type
5.2 By Type
5.3 By End User
5.4 By Region
-
Competitive Landscape
6.1 Company Profiles
6.2 Recent Developments
-
Market Forecast and Future Outlook
-
Appendix
Locked
